Ke Xin Wang
Chairman at SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Net worth: 686 918 $ as of 2024-03-30
Profile
Currently, Ke Xin Wang is Chairman for Jinzhou Ahon Pharmaceutical Co., Ltd. He is also on the board of Shanghai Fosun Pharmaceutical Development Co., Ltd. and Chengdu List Pharmaceutical Co., Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-12-12 | 215,200 ( 10.93% ) | 686 918 $ | 2024-03-30 |
Ke Xin Wang active positions
Companies | Position | Start |
---|---|---|
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Chairman | 2022-05-31 |
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Financial ConglomeratesFinance Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. engages in the investment in pharmaceutical industries. Its business activities include industrial investment; biotechnology development; and research and development of medical devices, chemical reagents and medicines. The company was founded on November 27, 2001 and is headquartered in Shanghai, China. | Director/Board Member | 2016-08-21 |
Chengdu List Pharmaceutical Co., Ltd.
Chengdu List Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu List Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese and western medicine raw materials. It also offers supplemental materials, intermediates, preparations, pharmaceutical products and equipment, biological products, health supplies, and medical packaging materials. Its business activities include product development, pharmaceutical technology development, installation and maintenance of pharmaceutical equipment, pharmaceutical engineering design, and technology consulting services. The company was founded on January 29, 2009 and is headquartered in Chengdu, China. | Director/Board Member | 2019-08-08 |
Jinzhou Ahon Pharmaceutical Co., Ltd.
Jinzhou Ahon Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jinzhou Ahon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicine. Its products include calf serum deproteinized injection, penehyclidine hydrochloride injection, calf serum deproteinized enteric-coated capsules, glutamine granules, nervous system drugs, oncology drugs, perioperative drugs, and pediatric medicine. The company is headquartered in Jinzhou, China. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
Private companies | 3 |
---|---|
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Financial ConglomeratesFinance Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. engages in the investment in pharmaceutical industries. Its business activities include industrial investment; biotechnology development; and research and development of medical devices, chemical reagents and medicines. The company was founded on November 27, 2001 and is headquartered in Shanghai, China. | Finance |
Jinzhou Ahon Pharmaceutical Co., Ltd.
Jinzhou Ahon Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jinzhou Ahon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicine. Its products include calf serum deproteinized injection, penehyclidine hydrochloride injection, calf serum deproteinized enteric-coated capsules, glutamine granules, nervous system drugs, oncology drugs, perioperative drugs, and pediatric medicine. The company is headquartered in Jinzhou, China. | Health Technology |
Chengdu List Pharmaceutical Co., Ltd.
Chengdu List Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu List Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese and western medicine raw materials. It also offers supplemental materials, intermediates, preparations, pharmaceutical products and equipment, biological products, health supplies, and medical packaging materials. Its business activities include product development, pharmaceutical technology development, installation and maintenance of pharmaceutical equipment, pharmaceutical engineering design, and technology consulting services. The company was founded on January 29, 2009 and is headquartered in Chengdu, China. | Health Technology |
- Stock Market
- Insiders
- Ke Xin Wang